Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1955396rdf:typepubmed:Citationlld:pubmed
pubmed-article:1955396lifeskim:mentionsumls-concept:C0995774lld:lifeskim
pubmed-article:1955396lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:1955396lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:1955396lifeskim:mentionsumls-concept:C0003234lld:lifeskim
pubmed-article:1955396lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:1955396pubmed:issue10lld:pubmed
pubmed-article:1955396pubmed:dateCreated1991-12-27lld:pubmed
pubmed-article:1955396pubmed:abstractTextNew anthracycline antibiotics, designated as obelmycins A, D, E, F and G, were isolated from the culture broth of a variant strain of beta-rhodomycin-producing Streptomyces violaceus A262, identified as beta-isorhodomycinone glycosides and gamma-isorhodomycinone glycosides and assayed for their in vitro cytotoxicities against murine leukemic L1210 cell culture and the antimicrobial activities in comparison with some known anthracyclines.lld:pubmed
pubmed-article:1955396pubmed:languageenglld:pubmed
pubmed-article:1955396pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955396pubmed:citationSubsetIMlld:pubmed
pubmed-article:1955396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955396pubmed:statusMEDLINElld:pubmed
pubmed-article:1955396pubmed:monthOctlld:pubmed
pubmed-article:1955396pubmed:issn0021-8820lld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:YoshimotoAAlld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:WatanabeYYlld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:TakeuchiTTlld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:SawaTTlld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:IshikuraTTlld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:NaganawaHHlld:pubmed
pubmed-article:1955396pubmed:authorpubmed-author:JohdoOOlld:pubmed
pubmed-article:1955396pubmed:issnTypePrintlld:pubmed
pubmed-article:1955396pubmed:volume44lld:pubmed
pubmed-article:1955396pubmed:ownerNLMlld:pubmed
pubmed-article:1955396pubmed:authorsCompleteYlld:pubmed
pubmed-article:1955396pubmed:pagination1130-40lld:pubmed
pubmed-article:1955396pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:meshHeadingpubmed-meshheading:1955396-...lld:pubmed
pubmed-article:1955396pubmed:year1991lld:pubmed
pubmed-article:1955396pubmed:articleTitleAnthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.lld:pubmed
pubmed-article:1955396pubmed:affiliationCentral Research Laboratories, Mercian Corporation, Fujisawa, Japan.lld:pubmed
pubmed-article:1955396pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1955396lld:pubmed